Magic mushrooms tested to help break opioid addiction

This study aimed to see if a single, guided session with the psychedelic compound psilocybin (found in 'magic mushrooms') could improve outcomes for people starting standard medication treatment (buprenorphine) for opioid addiction. Participants would have received either a high dose or a very low dose of psilocybin during a brief hospital stay, followed by several weeks of monitoring. The goal was to see if the psilocybin session helped people stay off opioids, stick with their treatment, and improve their mood and quality of life. The study was withdrawn before any participants were enrolled.